MHRA Cites Data Management and Integrity in GCP Inspections

International Pharmaceutical Regulatory Monitor
A A
Problems with inaccessible trial master files and confusing questionnaires are among the nonconforming practices cited in the latest GCP inspection report from the UK Medicines and Healthcare Products.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor